· Periodic Report
Q3 profit from the main business KRW 3.6 billion, down 80.9% from a year earlier
Kolon Life Science sold KRW 58.0 billion worth in Q3 and earned KRW 3.6 billion from its main business, down 80.9% from the same period last year.
KOLON LIFE SCIENCE Inc. Disclosures
102940 · KOSDAQ · Based on DART filings
Disclosures
1 total · 20 per page
Catch the next disclosure fast
Get app alerts for new disclosures from KOLON LIFE SCIENCE Inc..